Catalyst Wire Dossier Catalyst Wire Dossier

AHB-137 injection

AHB-137 · Ausper Biopharma Co., Ltd.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for AHB-137 injection, covering 2025-08-22 to 2025-12-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Antiviral Activity and Immune Response of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB) [Phase 2]

See pricing